Biomarin Pharmaceutical Stock Math Operators Price Series Summation
| BMRN Stock | USD 57.85 1.31 2.32% |
| Symbols |
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Biomarin Pharmaceutical Price Series Summation is a cross summation of Biomarin Pharmaceutical price series and its benchmark/peer.
Biomarin Pharmaceutical Technical Analysis Modules
Most technical analysis of Biomarin Pharmaceutical help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Biomarin from various momentum indicators to cycle indicators. When you analyze Biomarin charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Biomarin Pharmaceutical Predictive Technical Analysis
Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Biomarin Pharmaceutical. We use our internally-developed statistical techniques to arrive at the intrinsic value of Biomarin Pharmaceutical based on widely used predictive technical indicators. In general, we focus on analyzing Biomarin Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Biomarin Pharmaceutical's daily price indicators and compare them against related drivers, such as math operators and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Biomarin Pharmaceutical's intrinsic value. In addition to deriving basic predictive indicators for Biomarin Pharmaceutical, we also check how macroeconomic factors affect Biomarin Pharmaceutical price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
| 2023 | 2024 | 2025 | 2026 (projected) | Days Sales Outstanding | 95.61 | 84.48 | 97.15 | 99.68 | PTB Ratio | 3.66 | 2.21 | 1.99 | 3.91 |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Biomarin Pharmaceutical in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Biomarin Pharmaceutical's short interest history, or implied volatility extrapolated from Biomarin Pharmaceutical options trading.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Disruptive Technologies Invested few shares | |
 | Manufacturing Invested over 60 shares | |
 | Macroaxis Index Invested over 40 shares | |
 | Adviser Favorites Invested few shares | |
 | Artificial Intelligence Invested few shares | |
 | Momentum Invested over 30 shares | |
 | Impulse Invested over 200 shares | |
 | Hedge Favorites Invested few shares | |
 | Investor Favorites Invested few shares |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biomarin Pharmaceutical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in poverty. To learn how to invest in Biomarin Stock, please use our How to Invest in Biomarin Pharmaceutical guide.You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Will Biotechnology sector continue expanding? Could Biomarin diversify its offerings? Factors like these will boost the valuation of Biomarin Pharmaceutical. Projected growth potential of Biomarin fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Biomarin Pharmaceutical data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 1.243 | Earnings Share 2.69 | Revenue Per Share | Quarterly Revenue Growth 0.041 | Return On Assets |
Understanding Biomarin Pharmaceutical requires distinguishing between market price and book value, where the latter reflects Biomarin's accounting equity. The concept of intrinsic value—what Biomarin Pharmaceutical's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Biomarin Pharmaceutical's price substantially above or below its fundamental value.
It's important to distinguish between Biomarin Pharmaceutical's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Biomarin Pharmaceutical should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Biomarin Pharmaceutical's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.